SignatureFD’s BioCryst Pharmaceuticals BCRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$53.9K	Sell	5,666 -94	-2%	-$730	﹤0.01%	1678
2025 Q4	$44.9K	Sell	5,760 -187	-3%	-$1.35K	﹤0.01%	1714
2025 Q3	$45.1K	Hold	5,947	–	–	﹤0.01%	1692
2025 Q2	$53.3K	Sell	5,947 -235	-4%	-$2.19K	﹤0.01%	1550
2025 Q1	$46.4K	Sell	6,182 -507	-8%	-$4.09K	﹤0.01%	1613
2024 Q4	$50.3K	Buy	6,689 +384	+6%	+$2.92K	﹤0.01%	1582
2024 Q3	$47.9K	Sell	6,305 -293	-4%	-$2.23K	﹤0.01%	1597
2024 Q2	$40.8K	Buy	6,598 +5,599	+560%	+$30.9K	﹤0.01%	1615
2024 Q1	$5.08K	Sell	999 -684	-41%	-$3.85K	﹤0.01%	2536
2023 Q4	$10.1K	Buy	1,683 +910	+118%	+$5.27K	﹤0.01%	2254
2023 Q3	$5.47K	Buy	+773	New	+$5.55K	﹤0.01%	2456
2023 Q2	–	Sell	-93	Closed	-$776	–	3241
2023 Q1	$776	Buy	+93	New	+$895	﹤0.01%	3038
2022 Q4	–	Sell	-14	Closed	–	–	3296
2022 Q3	$0	Buy	+14	New	+$180	﹤0.01%	3113
2022 Q2	–	Sell	-33	Closed	-$1K	–	3114
2022 Q1	$1K	Buy	+33	New	+$529	﹤0.01%	2947